Warfarin Blood Thinner May Reduce Cancer Risk
Warfarin Blood Thinner May Reduce Cancer Risk
TELL US: Cancel You are leaving AARP.org and going to the website of our trusted provider. The provider’s terms, conditions and policies apply. Please return to AARP.org to learn more about other benefits. Your email address is now confirmed. You'll start receiving the latest news, benefits, events, and programs related to AARP's mission to empower people to choose how they live as they age. You can also by updating your account at anytime. You will be asked to register or log in. Cancel Offer Details Disclosures
Warfarin Blood Thinner May Reduce Cancer Risk
A study finds that it lowered the rates for 50-and-older patients
Getty Images Between 5 and 10 percent of adults are prescribed warfarin at some point in their lives, study finds. Use of warfarin, the blood thinner often taken to prevent , may lead to a lower incidence of among those 50 and older, according to an extensive study of health records in Norway. Published in JAMA Internal Medicine, the recently published study looked at the medical records of 1.25 million adults in Norway. It included people born from 1924 through 1954 who were living in Norway from 2006 through 2012. AARP Membership: For all types of cancers, the research indicated that warfarin reduced the risk by 16 percent. For specific cancers, risk reduction rates were 31 percent for prostate, 20 percent for lung, and 10 percent for breast. Rates for indicated no discernible difference between warfarin and non-warfarin users. For the purposes of the study, warfarin use was defined as a case in which a patient had used the drug at least six months under prescription and received a diagnosis of cancer at least two years after the use of the warfarin. Between 5 and 10 percent of adults in Western countries are prescribed warfarin at some point in their lives, according to the study, to treat a variety of . In Norway, 7.4 percent were categorized as warfarin users. Although it is a leading anticoagulant, alternatives to warfarin exist. The new research may influence choices. “This finding could have important implications for the selection of medications for patients needing anticoagulation,” researchers concluded.Also of Interest
TELL US: Cancel You are leaving AARP.org and going to the website of our trusted provider. The provider’s terms, conditions and policies apply. Please return to AARP.org to learn more about other benefits. Your email address is now confirmed. You'll start receiving the latest news, benefits, events, and programs related to AARP's mission to empower people to choose how they live as they age. You can also by updating your account at anytime. You will be asked to register or log in. Cancel Offer Details Disclosures